Credit Agricole’s PDL BioPharma, Inc. PDLI Stock Holding History

Credit Agricole’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-334,538	Closed	-$1.05M	–	715
2019 Q2	$1.05M	Sell	334,538 -334,538	-50%	-$1.09M	0.06%	214
2019 Q1	$2.49M	Sell	669,076 -102,568	-13%	-$346K	0.14%	175
2018 Q4	$2.24M	Buy	771,644 +300,000	+64%	+$824K	0.13%	198
2018 Q3	$1.24M	Buy	471,644 +221,644	+89%	+$544K	0.06%	258
2018 Q2	$586K	Hold	250,000	–	–	0.04%	259
2018 Q1	$736K	Hold	250,000	–	–	0.05%	228
2017 Q4	$686K	Sell	250,000 -30,000	-11%	-$92.2K	0.05%	241
2017 Q3	$950K	Buy	280,000 +230,000	+460%	+$640K	﹤0.01%	1116
2017 Q2	$124K	Hold	50,000	–	–	﹤0.01%	1344
2017 Q1	$114K	Buy	50,000 +12,942	+35%	+$28.6K	﹤0.01%	1566
2016 Q4	$79K	Buy	+37,058	New	+$103K	﹤0.01%	1398
2013 Q4	–	Sell	-617,659	Closed	-$4.92M	–	1796
2013 Q3	$4.92M	Buy	+617,659	New	+$4.97M	0.02%	604

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Credit Agricole's PDLI Position: Q3 2019 in Review

Credit Agricole sold out of PDL BioPharma, Inc. (PDLI) in Q3 2019, closing a stake of 334,538 shares — an estimated $1.05M sold.

Credit Agricole first reported a position in PDLI in Q3 2013 and held it in 12 quarters. The position peaked at $4.92M in Q3 2013. 140 funds tracked by Wall St. Rank hold PDLI as of Q3 2019.

Credit Agricole reported no remaining PDL BioPharma, Inc. position as of Q3 2019 after selling out during the quarter.
Credit Agricole sold 334,538 PDL BioPharma, Inc. shares in Q3 2019, an estimated $1.05M.
Credit Agricole first reported a position in PDL BioPharma, Inc. in Q3 2013 and held it in 12 quarters.
Credit Agricole's PDL BioPharma, Inc. position peaked at $4.92M in Q3 2013.
140 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2019.

Based on Credit Agricole's 13F filing for Q3 2019, filed 8 Nov 2019.